KIRSKE DAVID (Chief Financial Officer) sold 7.0% of their position (11.77K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $33.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/5/2026ACC: 0001501697-26-000078
Officer· Chief Financial Officer
Since Aug 2025
-11.77K
Net shares
Net seller
$33.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.77K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.77K
Price / share
$2.86
Trade value
$33.66K
% of position
7.0%
10/1/2026
167.75K→155.98K
Total
Net shares
−11.77K
Net value
-$33.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | S · Sale | −11.77K | $2.86 | $33.66K | 7.0% | 167.75K | 155.98K |
| Total | −11.77K | -$33.66K | ||||||
Derivative Transactions0
No derivative transactions reported